|
Delayed
London S.E.
01:29:59 28/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 82.50 GBX | 0.00% |
|
0.00% | +2.48% |
| 15/10 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 15/10 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
Evolution of the Average Target: Arecor Therapeutics plc
Evolution of the Target Price: Arecor Therapeutics plc
Changes in Analyst Recommendations: Arecor Therapeutics plc
8e7f6d0a.J-e8GUz2ssmLh2OtTTKnneEQEAGac25KpOG5jemhBlQ.RLKPTxip_qzSxDrMfB-e0NRZYW7MEh8-wI_X5bbzSRxt1_F3IZjfjLrkLg~774a9424f0a13b3615cd00169759d7ab
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +203.64% | ||||
| +41.32% | |||||
| +28.63% | |||||
| +9.56% | |||||
| +12.15% | |||||
| +19.23% | |||||
| +39% | |||||
| +42.31% | |||||
| +6.5% | |||||
| +35.02% | |||||
| Average | +43.74% | |||||
| Weighted average by Cap. | +26.21% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8250GBP
Average target price
2.505GBP
Spread / Average Target
+203.64%
High Price Target
2.510GBP
Spread / Highest target
+204.24%
Low Price Target
2.500GBP
Spread / Lowest Target
+203.03%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- AREC Stock
- Consensus Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
